• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络的乳腺癌生物标志物发现的共识基因特征。

Network based consensus gene signatures for biomarker discovery in breast cancer.

机构信息

University of Bonn, Bonn-Aachen International Center for IT, Bonn, Germany.

出版信息

PLoS One. 2011;6(10):e25364. doi: 10.1371/journal.pone.0025364. Epub 2011 Oct 25.

DOI:10.1371/journal.pone.0025364
PMID:22046239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3201953/
Abstract

Diagnostic and prognostic biomarkers for cancer based on gene expression profiles are viewed as a major step towards a better personalized medicine. Many studies using various computational approaches have been published in this direction during the last decade. However, when comparing different gene signatures for related clinical questions often only a small overlap is observed. This can have various reasons, such as technical differences of platforms, differences in biological samples or their treatment in lab, or statistical reasons because of the high dimensionality of the data combined with small sample size, leading to unstable selection of genes. In conclusion retrieved gene signatures are often hard to interpret from a biological point of view. We here demonstrate that it is possible to construct a consensus signature from a set of seemingly different gene signatures by mapping them on a protein interaction network. Common upstream proteins of close gene products, which we identified via our developed algorithm, show a very clear and significant functional interpretation in terms of overrepresented KEGG pathways, disease associated genes and known drug targets. Moreover, we show that such a consensus signature can serve as prior knowledge for predictive biomarker discovery in breast cancer. Evaluation on different datasets shows that signatures derived from the consensus signature reveal a much higher stability than signatures learned from all probesets on a microarray, while at the same time being at least as predictive. Furthermore, they are clearly interpretable in terms of enriched pathways, disease associated genes and known drug targets. In summary we thus believe that network based consensus signatures are not only a way to relate seemingly different gene signatures to each other in a functional manner, but also to establish prior knowledge for highly stable and interpretable predictive biomarkers.

摘要

基于基因表达谱的癌症诊断和预后生物标志物被视为迈向更好的个性化医疗的重要一步。在过去的十年中,已经发表了许多使用各种计算方法的研究。然而,当比较针对相关临床问题的不同基因特征时,通常只观察到很小的重叠。这可能有多种原因,例如平台的技术差异、生物样本或其在实验室中的处理差异,或由于数据的高维度与小样本量相结合而导致的统计原因,从而导致基因选择不稳定。总之,从生物学角度来看,检索到的基因特征往往难以解释。我们在这里证明,通过将它们映射到蛋白质相互作用网络上,从一组看似不同的基因特征构建共识特征是可能的。通过我们开发的算法确定的密切基因产物的上游常见蛋白,在过表达的 KEGG 途径、疾病相关基因和已知药物靶标方面显示出非常清晰和显著的功能解释。此外,我们表明,这样的共识特征可以作为乳腺癌中预测性生物标志物发现的先验知识。在不同数据集上的评估表明,与从微阵列上的所有探针集学习得到的特征相比,从共识特征派生的特征具有更高的稳定性,而同时至少具有相同的预测能力。此外,它们在富集途径、疾病相关基因和已知药物靶标方面具有明显的可解释性。总之,我们因此相信,基于网络的共识特征不仅是一种以功能方式将看似不同的基因特征相互关联的方法,而且是建立高度稳定和可解释的预测性生物标志物的先验知识的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/242aa5cb6dd5/pone.0025364.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/eb9876d61dff/pone.0025364.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/67fe592d3bd8/pone.0025364.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/d39387f25ca3/pone.0025364.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/4d92385bed3a/pone.0025364.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/7352666d6541/pone.0025364.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/90e549ee63d2/pone.0025364.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/ef8f6347a9be/pone.0025364.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/cb5d77a3b70a/pone.0025364.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/242aa5cb6dd5/pone.0025364.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/eb9876d61dff/pone.0025364.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/67fe592d3bd8/pone.0025364.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/d39387f25ca3/pone.0025364.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/4d92385bed3a/pone.0025364.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/7352666d6541/pone.0025364.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/90e549ee63d2/pone.0025364.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/ef8f6347a9be/pone.0025364.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/cb5d77a3b70a/pone.0025364.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a63/3201953/242aa5cb6dd5/pone.0025364.g009.jpg

相似文献

1
Network based consensus gene signatures for biomarker discovery in breast cancer.基于网络的乳腺癌生物标志物发现的共识基因特征。
PLoS One. 2011;6(10):e25364. doi: 10.1371/journal.pone.0025364. Epub 2011 Oct 25.
2
Significant random signatures reveals new biomarker for breast cancer.显著的随机特征揭示了乳腺癌的新生物标志物。
BMC Med Genomics. 2019 Nov 8;12(1):160. doi: 10.1186/s12920-019-0609-1.
3
Genes and functions from breast cancer signatures.乳腺癌标志物的基因和功能。
BMC Cancer. 2018 Apr 27;18(1):473. doi: 10.1186/s12885-018-4388-4.
4
Prognostic gene signatures for patient stratification in breast cancer: accuracy, stability and interpretability of gene selection approaches using prior knowledge on protein-protein interactions.用于乳腺癌患者分层的预后基因特征:利用蛋白质 - 蛋白质相互作用的先验知识选择基因的方法的准确性、稳定性和可解释性。
BMC Bioinformatics. 2012 May 1;13:69. doi: 10.1186/1471-2105-13-69.
5
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.模糊逻辑选择作为识别乳腺癌分子分级特征的一种新型可靠工具——INNODIAG研究
BMC Med Genomics. 2015 Feb 7;8:3. doi: 10.1186/s12920-015-0077-1.
6
Identifying cancer biomarkers by network-constrained support vector machines.通过网络约束支持向量机识别癌症生物标志物。
BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.
7
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.三阴性乳腺癌的同质数据集可用于鉴定新的预后和预测特征。
PLoS One. 2011;6(12):e28403. doi: 10.1371/journal.pone.0028403. Epub 2011 Dec 29.
8
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
9
Including network knowledge into Cox regression models for biomarker signature discovery.将网络知识纳入Cox回归模型以发现生物标志物特征。
Biom J. 2014 Mar;56(2):287-306. doi: 10.1002/bimj.201300035. Epub 2014 Jan 15.
10
NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.NETBAGs:一种基于网络的聚类方法,带有用于癌症亚型分析的基因特征。
Biomark Med. 2015;9(11):1053-65. doi: 10.2217/bmm.15.96. Epub 2015 Oct 26.

引用本文的文献

1
Evaluating adaptive stress response gene signatures using transcriptomics.利用转录组学评估适应性应激反应基因特征
Comput Toxicol. 2021 Nov 1;20:1-9. doi: 10.1016/j.comtox.2021.100179.
2
Bayesian Gene Selection Based on Pathway Information and Network-Constrained Regularization.基于通路信息和网络约束正则化的贝叶斯基因选择。
Comput Math Methods Med. 2021 Aug 4;2021:7471516. doi: 10.1155/2021/7471516. eCollection 2021.
3
Applications of Bayesian network models in predicting types of hematological malignancies.贝叶斯网络模型在预测血液系统恶性肿瘤类型中的应用。

本文引用的文献

1
Diagnostic signatures from microarrays: a bioinformatics concept for personalized medicine.微阵列的诊断特征:个性化医疗的生物信息学概念。
Drug Discov Today. 2004 Dec 15;9(24 Suppl):S32-6.
2
Pathway Commons, a web resource for biological pathway data.Pathway Commons,一个用于生物通路数据的网络资源。
Nucleic Acids Res. 2011 Jan;39(Database issue):D685-90. doi: 10.1093/nar/gkq1039. Epub 2010 Nov 10.
3
Permutation P-values should never be zero: calculating exact P-values when permutations are randomly drawn.排列P值永远不应为零:当排列是随机抽取时计算精确P值。
Sci Rep. 2018 May 3;8(1):6951. doi: 10.1038/s41598-018-24758-5.
4
Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.基于公共表达数据的基因调控网络中阿尔茨海默病候选基因的分析策略。
J Alzheimers Dis. 2017;59(4):1237-1254. doi: 10.3233/JAD-170011.
5
A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways.一种与HER2阳性乳腺癌新辅助化疗反应、预后及淋巴细胞浸润相关的基质免疫模块与激素通路呈负相关。
PLoS One. 2016 Dec 22;11(12):e0167397. doi: 10.1371/journal.pone.0167397. eCollection 2016.
6
Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.生物网络驱动的基因选择确定了一个基质免疫模块作为三阴性乳腺癌预后的关键决定因素。
Oncoimmunology. 2015 Jun 24;5(1):e1061176. doi: 10.1080/2162402X.2015.1061176. eCollection 2016.
7
Regularized logistic regression with network-based pairwise interaction for biomarker identification in breast cancer.用于乳腺癌生物标志物识别的基于网络的成对相互作用的正则化逻辑回归
BMC Bioinformatics. 2016 Feb 27;17:108. doi: 10.1186/s12859-016-0951-7.
8
A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients.一种潜在的预测乳腺癌患者无转移生存期的预后长链非编码RNA特征。
Sci Rep. 2015 Nov 9;5:16553. doi: 10.1038/srep16553.
9
Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers.疾病特异性生物标志物的通路映射与开发:基于蛋白质的网络生物标志物
J Cell Mol Med. 2015 Feb;19(2):297-314. doi: 10.1111/jcmm.12447. Epub 2015 Jan 5.
10
Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models.使用两层因果模型对生物网络扰动进行量化,以获得机制见解和诊断。
BMC Bioinformatics. 2014 Jul 11;15:238. doi: 10.1186/1471-2105-15-238.
Stat Appl Genet Mol Biol. 2010;9:Article39. doi: 10.2202/1544-6115.1585. Epub 2010 Oct 31.
4
Translating cancer research into targeted therapeutics.将癌症研究转化为靶向治疗。
Nature. 2010 Sep 30;467(7315):543-9. doi: 10.1038/nature09339.
5
Extracting consistent knowledge from highly inconsistent cancer gene data sources.从高度不一致的癌症基因数据源中提取一致的知识。
BMC Bioinformatics. 2010 Feb 5;11:76. doi: 10.1186/1471-2105-11-76.
6
The transcriptional network for mesenchymal transformation of brain tumours.脑肿瘤间质转化的转录网络。
Nature. 2010 Jan 21;463(7279):318-25. doi: 10.1038/nature08712. Epub 2009 Dec 23.
7
GeneSigDB--a curated database of gene expression signatures.GeneSigDB——一个经过精心整理的基因表达特征数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D716-25. doi: 10.1093/nar/gkp1015. Epub 2009 Nov 24.
8
Annotating the human genome with Disease Ontology.用疾病本体论注释人类基因组。
BMC Genomics. 2009 Jul 7;10 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2164-10-S1-S6.
9
Statistical aspects of gene signatures and molecular targets.基因特征和分子靶点的统计学方面。
Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S19-21.
10
KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor.KEGGgraph:R语言和生物导体中KEGG通路的图形化方法
Bioinformatics. 2009 Jun 1;25(11):1470-1. doi: 10.1093/bioinformatics/btp167. Epub 2009 Mar 23.